Ozone Therapy Research

This comprehensive review examines the role of ozone therapy in treating musculoskeletal disorders affecting bones, joints, muscles, and connective tissues.

The authors found that ozone therapy demonstrates considerable therapeutic applications through its anti-inflammatory and analgesic properties, modulating pain and inflammation across conditions including osteoarthritis, fractures, and chronic pain syndromes.

However, the review highlights safety concerns regarding potential toxicity of oxidizing agents, inconsistencies in patient responses, and the need for stringent administration protocols. The authors call for additional high-quality, long-term studies and the development of international clinical guidelines for broader medical acceptance.

This umbrella review synthesized findings from multiple systematic reviews evaluating ozone therapy for knee osteoarthritis (OA). The authors assessed both efficacy outcomes (pain reduction, functional improvement) and safety profiles across different ozone delivery methods.

The analysis found consistent evidence that ozone therapy — particularly intra-articular injections — provides significant pain relief and functional improvement in knee OA patients compared to controls. The treatment demonstrated a favorable safety profile, with adverse events being generally mild and self-limiting.

However, the authors noted that the overall quality of the included systematic reviews was variable, and many of the underlying primary studies had methodological limitations including small sample sizes and inconsistent outcome measures. While the direction of evidence supports ozone therapy as a beneficial adjunct for knee OA, the authors call for higher-quality randomized controlled trials to strengthen the evidence base.

This evidence and gap map systematically catalogued the available clinical research on medical ozone therapy across a wide range of health conditions. The authors screened thousands of records and mapped the existing evidence by condition, study design, and quality level.

The map revealed that ozone therapy has been studied across at least 94 distinct clinical conditions. The strongest concentrations of evidence were found in musculoskeletal disorders (particularly low back pain and knee osteoarthritis), wound healing (including diabetic foot ulcers), and dentistry. These areas had multiple systematic reviews and randomized controlled trials supporting clinical benefit.

Significant evidence gaps were identified in neurological conditions, metabolic disorders, and several other areas where only preliminary or low-quality studies exist. The authors concluded that while ozone therapy shows promise as an integrative medicine tool with a broad evidence base, targeted high-quality research is needed to fill the identified gaps and move the field forward.

This systematic review and meta-analysis evaluated the efficacy of ozone therapy as an adjunct to standard treatment for COVID-19 patients. The authors pooled data from available clinical studies comparing standard care plus ozone therapy versus standard care alone.

The meta-analysis found that adjuvant ozone therapy was associated with a statistically significant reduction in mortality risk and shorter hospital length of stay compared to standard treatment alone. Some analyses also suggested trends toward reduced ICU admission, although not all secondary outcomes reached statistical significance.

The authors acknowledged that the certainty of evidence was low due to the limited number of included studies, heterogeneity in ozone delivery protocols, and variability in study designs. They concluded that while the preliminary results are encouraging, large-scale randomized controlled trials with standardized ozone protocols are needed to confirm these findings and establish optimal treatment parameters.

This review examines the antimicrobial and immune-enhancing properties of medical ozone therapy.

Ozone can directly inactivate pathogens through oxidation while simultaneously stimulating immune responses, potentially offering adjunctive benefits for various infections.

This systematic review and meta-analysis compared ozone therapy to steroids and placebo for low back pain in adults, searching four databases (Medline, Scopus, Lilacs, EMBASE) covering 1966-2018.

From 779 identified articles, six randomized clinical trials with 717 participants were selected. At 3 months, no significant difference was found between ozone and comparison groups. However, at 6 months, ozone therapy demonstrated significantly greater effectiveness than other therapies (RR 2.2, 95% CI: 1.87-2.60, p < 0.00001).

The authors cautioned that these results are not definitive, as the included studies carried moderate to high risk of bias, limiting the strength of the evidence.

Comprehensive review of ozone therapy pharmacology and clinical applications.

This scientific review presents the biochemical rationale for medical ozone therapy.

Low-dose ozone triggers adaptive responses including upregulation of antioxidant enzymes, improved oxygen delivery to tissues, and modulation of inflammatory processes.

This clinical review examines the mechanisms and applications of medical ozone therapy.

Controlled ozone exposure can trigger beneficial adaptive responses (hormesis), potentially enhancing antioxidant defenses, immune function, and tissue oxygenation.

This systematic review and meta-analysis evaluated ozone therapy for low back pain caused by disc herniation, searching electronic databases from 1966 through September 2011.

Eight observational studies and four randomized controlled trials were analyzed. Intradiscal ozone injection received evidence level II-3 with recommendation grade 1C, while paravertebral ozone injection demonstrated stronger evidence at level II-1 with recommendation grade 1B.

The authors concluded that percutaneous ozone therapy yields positive results with low morbidity rates for chronic low back pain, though significant methodological limitations temper the strength of these findings.